Harvard Bioscience Inc (HBIO) Dividend History

Company News

• Harvard Bioscience Appoints John Duke to Board of Directors

  Harvard Bioscience announced the appointment of John Duke to its board of directors and the retirement of Thomas Loewald. The company also reported its first quarter 2025 financial results.

  GlobeNewswire Inc.

  Featured Companies: GLW
• Harvard Bioscience Announces First Quarter 2025 Financial Results

  Harvard Bioscience reported Q1 2025 results with revenues of $21.8 million, down from $24.5 million in Q1 2024. The company recorded a net loss of $50.3 million, which included a $48 million goodwill impairment. Adjusted EBITDA was $0.8 million, down from $1.6 million in the prior year quarter.

  GlobeNewswire Inc.
• Harvard Bioscience Announces CFO Transition

  Harvard Bioscience announced the resignation of its Chief Financial Officer Jennifer Cote, effective upon the filing of the company's Q1 2025 report. The company has appointed Mark Frost as Interim CFO, who brings over 30 years of financial and executive experience.

  GlobeNewswire Inc.
• Harvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025

  Harvard Bioscience, a leading developer of life science technologies, announced its participation in two investor conferences in March 2025, where the company's management will host one-on-one meetings and fireside chats.

  GlobeNewswire Inc.
• Harvard Bioscience Schedules Fourth Quarter 2024 Earnings Conference Call for March 12, 2025 at 8:00 AM ET

  Harvard Bioscience, Inc. will announce its Q4 2024 financial results on March 12, 2025 and hold a conference call to discuss the results.

  GlobeNewswire Inc.